Alexey A. Zeifman

发表

CSAR Scoring Challenge Reveals the Need for New Concepts in Estimating Protein-Ligand Binding Affinity

Fedor N. Novikov, Alexey A. Zeifman, Oleg V. Stroganov, 2011, J. Chem. Inf. Model..

Lead Finder docking and virtual screening evaluation with Astex and DUD test sets

Fedor N. Novikov, Alexey A. Zeifman, Oleg V. Stroganov, 2012, Journal of Computer-Aided Molecular Design.

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Alexey A. Zeifman, O. Ottmann, D. Hoelzer, 2014, Leukemia.

Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment

Alexey A. Zeifman, D. Guranda, G. Chilov, 2018, Leukemia & lymphoma.

Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library.

Harald Hübner, Peter Gmeiner, Jens Carlsson, 2017, ACS chemical biology.

Hit clustering can improve virtual fragment screening: CDK2 and PARP1 case studies

Alexey A. Zeifman, Oleg V Stroganov, Fedor N Novikov, 2012, Journal of Molecular Modeling.

TSAR, a new graph–theoretical approach to computational modeling of protein side‐chain flexibility: Modeling of ionization properties of proteins

Alexey A. Zeifman, Viktor S. Stroylov, F. Novikov, 2011, Proteins: Structure, Function, and Bioinformatics.

Rational design and synthesis of novel Syk-kinase inhibitors

Alexey A. Zeifman, A. Lipkin, T. Rakitina, 2012 .

An explicit account of solvation is essential for modeling Suzuki-Miyaura coupling in protic solvents.

Alexey A. Zeifman, F. Novikov, V. Stroylov, 2015, Dalton transactions.

Exhaustive conformational search for transition states: the case of catechol O-methyltransferase active site

Alexey A. Zeifman, I. S. Bushmarinov, F. Novikov, 2017 .